WEEKLY UPDATE
Aug 31
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  MDRD GFR
Slides/audio/handouts:    RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  :  ADC-2007(a)  :  RPA-2007(s/a)  :  RRI-2007(s/a/h)  : 
Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Hogg  

Meyrier  

  DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Flash slide/audio
(ASN Clinical Nephrology Conference, November, 2007)
Hogg: What are the long-term options to treat frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome? What is the optimal way to use steroids in such patients. What about non-corticosteroid therapies? Can treatment be stopped? If so, when? What is the role for cyclosporine and mycophenolate in such patients? Meyrier: How do we treat steroid-resistant, primary FSGS in adults? How do we rule out secondary FSGS? When do we look for familial (genetic) disease, and how? Does histopathology matter? What is the response to corticosteroids? What is undertreatment? What is overtreatment? What are the roles of alkylating agents, tacrolimus, cyclosporine, sirolimus, MMF, and rituximab?
(more...)


Hypertension, Cardiovascular
Fruit and veggie intake lowers DM risk
Hemoglobin A1c as a risk factor in nondiabetics
Metabolically benign obesity
Fat without MS, MS without fat
Ankle brachial index calculations
Allopurinol lowers BP in kids
Preeclampsia increases CKD risk
Higher LV mass with primary aldo
Ambulatory BP in kids: standards from AHA
CKD, ESRD
Concept of AKI (historical)
Phosphate levels link to increased BP in CKD5D
Balkan nephropathy etiology (review)
Risk of microalbuminuria up in CKD patient relatives
Dual blockade meta-analysis
Pravastatin does not retard progression
Spurious hyperphosphatemia due to Alteplase
Triple blockade RCT
Removal of failed allograft cures ascites
Consistent control of MBD in incident patients
Aspirin use ups AV fistula survival
Oral sodium phosphate bowel preps bad
Higher strength lanthanum good
High phosphate ups infection risk
Low bone activity and CAC
Increasing BMI linked to CKD risk
Chicken lowers microalbuminuria
Phosphate-containing food additives
High alk phos a risk marker in DOPPS
Zoledronic acid infusions and renal risk
Glycated Hb vs. glycated albumin
High CRP linked to anemia in early stage CKD
Predictors of GFR change
Physical activity linked to slower progression in women
Clinical Nephrology
Furosemide for hypercalcemia no good
Preop ACEI/ARB no good
Amiloride helps Li-induced polyuria
Net acid excretion in vegans vs. omnivores
New corrected calcium equation




ASN Renal Week 2007
now in MP3
AUDIOFILE LIST (Renal Week 2007)

(30 talks)
PREVENTION AND TREATMENT OF HUMAN ACUTE KIDNEY: BREAKING DOWN THE BARRIERS

Evolving Conceptual Model for Human AKI
Ravindra L. Mehta, MD, FASN

Using Biomarkers for AKI: What, How and When?
Bruce A. Molitoris, MD

Immunomodulatory Cytokines in Human AKI
Bertrand L. Jaber, MD, FASN

Prognosis of Human AKI: Predictive Factors for Recovery and Progression
Jonathan Himmelfarb, MD

UPDATE ON THE RAS "IT'S NOT YOUR FATHER'S RENIN-ANGIOTENSIN SYSTEM"

The (Pro)Renin Receptor
Genevieve Nguyen, MD, PhD

Intrarenal vs. Systemic AT1 Receptor: Which Mediates Injury?
Steven D. Crowley, MD

ACE2 and Ang1-7 Barry M. Brenner Endowed Lectureship
Carlos M. Ferrario

ACUTE KIDNEY INJURY: CONTEMPORARY THERAPY

Evolving Practices in the Management of AKI in the ICU
Lakhmir S. Chawla, MD

Role of Intensive Renal Replacement Therapy in AKI
John A. Kellum

World-wide Practice of Extracorporeal Treatment of AKI
Zaccaria Ricci, MD

Treatment of AKI in Children: Conservative Management to RRT
Timothy E. Bunchman, MD

ADSORBENTS IN DIALYSIS

The Bases of Mass Separation and Characteristics of Sorbent Materials
Edward F. Leonard, PhD

Biocompatibility of Adsorbent Systems
Nicholas A. Hoenich, PhD

Sorbent Augmented Dialysis Systems
James F. Winchester, MD

Use of Adsorbents in ARF Therapy
Ciro Tetta

FUNCTIONAL DECLINE AND FRAILTY IN CHRONIC KIDNEY DISEASE

Physical Functioning in ESRD: Clinical Significance of Deficits and Impact of Interventions
Patricia Lynn Painter, PhD

Frailty in CKD
Michael G. Shlipak, MD

Quality of Life and Symptoms in Elderly ESRD Patients
Steven D. Weisbord, MD, FASN

MEASURES OF KIDNEY FUNCTION BEYOND CREATININE

Estimating Equations and Direct Measurements of GFR: Assessing CKD Progression
Harold I. Feldman, MD, FASN

Determining GFR in the Clinical Setting: Should We Use Estimating Equations at All?
Fernando G. Cosio, MD, FASN

NON-RENAL DIABETIC COMPLICATIONS

New Approaches to Diabetic Retinopathy
Thomas W. Gardner, MD, MS

Diabetic Neuropathy: Mechanisms and Management
Eva L. Feldman, MD, PhD

Vascular Complications of Diabetes Microvascular Versus Macrovascular Complications
John C. Rutledge, MD

REAL LIFE AFTER TRANSPLANTATION

Pregnancy after Transplant: Newer Immunosuppressive Agents and the Outcome of Pregnancy and the Offspring
Dianne B. McKay, MD

Nagging Problems after Transplant: Hair Loss, Diarrhea, Gingival Hyperplasia, Muscle Weakness, Recurrent FSGS
Deborah B. Adey, MD

Prostate Cancer and Transplant
Maxwell V. Meng, MD

MEMBRANOUS NEPHROPATHY: BENCH TO BEDSIDE

Evolution of our Understanding of Membranous Nephropathy
William G. Couser, MD, FASN

Complement Activation in Membranous Nephropathy: Can We Intervene Therapeutically
Richard J. Quigg, MD

Cellular Response to Injury in Membranous Nephropathy
Stuart J. Shankland, MD, MBChB, FRCPC, FASN

Treatment Options in MN: Towards Pathophysiology - Driven Therapies
Pierre M. Ronco, MD, PhD




    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: September 04, 2008 (S04)
S04 Nanodevice detects local paracrine signalling among immune cells
S04 Tired of jogging to burn more calories? Try working on a crossword puzzle.
S03 Sleep loss, even transient, increases NF-kappaB activity in humans.
S03 Higher serum calcium levels within the normal range associated with increased fatal prostate cancer risk in NHANES.
S03 Exercise increases risk of catching the flu, while quercetin lowers this risk (in mice)
S03 RPA and ESRD networks launch kidney patient safety initiative, including a new website.
S03 Cortinarius mushroom induced kidney failure in the news - Horse Whisperer author Nicholas Evans being the latest victim
S02 In vitro studies suggest role for antihistamine clemizole in treating hepatitis C
S02 TORC gene linked to both appetite regulation and fertility
S02 Think your fiance will make the perfect husband? Better first check his vasopressin receptor genotype!
S02 Genetic data stored at NIH temporarily withdrawn due to privacy concerns raised by new method of forensic SNP analysis
S02 How Tulane University hospital coped with Gustav evacuation
S02 Want to live longer? Take the stairs instead of the elevator.
S02 AJKD: Temporary iron depletion and relative thrombocytosis may underline increased mortality with high doses of EPO.
A31 HDCN: Relapsing MCD and FSGS; 30 new audiofiles from 8 sessions of RW07; AKI after oral phosphate
A30 Off topic weekend fun and games: Inference riddles for the whole family to play
A29 Study suggests that flu shots may not reduce mortality in the elderly.
A29 ESRD Network 13 - Hurricane information
A29 Variant Creutzfeld-Jakob disease transmissible by blood transfusion.
A29 Heated seats (applies to dialysis chairs) raise scrotal temperatures and affect sperm.
General Advances Emphasis
archive
Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.
Although this is now well known, Heher et al review the latest information about this source of potential acute renal failure; especially important given the widespread use of this method of bowel preparation; from the September issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Sympathetic overactivity - the Cinderella of cardiovascular risk factors in dialysis patients
Vonend, Rump, and Ritz discuss the evidence for SNS overactivity in ESRD and what treatments may best mitigate this; from the July/August issue of Seminars in Dialysis. (more...)

The aggravating mechanisms of aldosterone on kidney fibrosis
Remuzzi and colleagues discuss how aldosterone may promote kidney fibrosis, and the potential benefits of halting this process; in the August 2008 issue of the J Am Soc Nephrol (JASN) (more...)

Pharmacogenetics of immunosuppressants: progress, pitfalls and promises
Cattaneo and colleagues review the data on polymorphisms of the thiopurine-S-methyltransferase and cytochrome P450 3A5 genotypes, but also discuss new research on the genetic variation of the targets of immunosuppresant drugs; in the July 2008 issue of the Am J Transplant. (more...)

Exercise and Dialysis
Johansen reviews the evidence of what the benefits are, what are the best types to recommend, and the new recs from the American College of Sports Medicine and the AHA for older individuals and for those with chronic diseases; from the July issue of Hemodialysis International. (more...)

Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
Abaterusso and colleagues discuss the realities and practical approaches of treating CKD in the elderly; from the July issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

When is it appropriate to order an ionized calcium?
Calvi and Bushinsky discuss how ionized calcium measurement may be better than albumin-corrected calcium in a number of intensive care situations, and also in some ambulatory settings; from the July issue of the J Am Soc Nephrol (JASN) (more...)

Lipid abnormalities and cardiovascular risk in renal disease
Ritz and Wanner review the effects of CKD on lipids, the evidence that lipid control may slow progression, and suggest treatment regimens in this population; from the June issue of the J Am Soc Nephrol (JASN) (more...)

Role of remission clinics in the longitudinal treatment of CKD
What is a remission clinic for CKD patients, and what are the results in terms of progression when patients are aggressively monitored and treated in this way? Ruggenenti and colleagues tells us, in the June issue of the J Am Soc Nephrol (JASN) (more...)

Staging of chronic kidney disease: time for a course correction
Bauer et al tell us why the NKF KDOQI staging system is seriously flawed; from the May issue of the J Am Soc Nephrol (JASN) (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...











 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99